306
Participants
Start Date
September 30, 2005
Primary Completion Date
January 31, 2008
Study Completion Date
January 31, 2008
Retigabine
Oral tablet. The starting daily dose will be 300 mg/day administered orally in three equally divided doses. This dosage will be increased by 150 mg/day (50 mg/dose) at 1-week intervals (titration phase). At the beginning of Week 7, patients will enter a 12 week maintenance phase
Placebo
Oral tablet.
Fundacion Lennox, Córdoba
Sanatorio del Salvador II, Córdoba
Beth Israel Medical Center, New York
Hospital de Psiquiatria San Fernando, IMSS, Mexico City
CIF BIOTEC, Medica Sur, Tlalpan
Milton S. Hershey Medical Center, Hershey
Hospital of the University of Pennsylvania, Philadelphia
Mid-Atlantic Epilepsy and Sleep Center, Bethesda
University of Virginia Comprehensive Epilepsy Program, Charlottesville
Virginia Commonwealth University Medical Center, Richmond
Asheville Neurology Specialists, Asheville
University of Florida -- Shands Jacksonville, Jacksonville
University of Miami, Miami
Lovelace Scientific Resources, Sarasota
University of Alabama -- Department of Neurology/Epilepsy Center, Birmingham
Neurology Clinic, Northport
North Alabama Neuroscience Research Associates, Huntsville
Meharry Medical College, Nashville
Vanderbilt University Medical Center, Nashville
University of Kentucky, Lexington
Instituto Nacional de Neurologia y Neurocirugia, La Fama
Medical University of Ohio at Toledo, Toledo
Antiguo Hospital Civil de Guadalajara, Guadalajara
Henry Ford Hospital, Detroit
McFarland Clinic, Ames
Minnesota Epilepsy Group, P.A., Saint Paul
The Comprehensive Epilepsy Care Center for Children and Adults, Chesterfield
Hospital y Clinica OCA S.A. de C.V., Monterrey
Clinical Trials Inc., Little Rock
Medical City Dallas Hospital, Dallas
Neurological Clinic of Texas, Dallas
Memorial Hermann Hospital, Houston
Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí City
University of Colorado Health Science Center, Denver
Delta Waves, Colorado Springs
Barrow Neurological Institute, Phoenix
University of Southern California, Los Angeles
West Los Angeles VA Healthcare Center, Los Angeles
UCSD Thornton Hospital, La Jolla
Oregon Neurology PC, Tualatin
Hospital Italiano de Buenos Aires, Capital Federal
"Hospital General de Agudos Dr. J.M. Ramos Mejia", Capital Federal
"Hospital General de Agudos Dr. Teodoro Alvarez", Capital Federal
Hospital Privado Centro Medico de Cordoba, Córdoba
Hospital Universitario Prof Edgard Santos -- UFBA, Salvador
Hospital das Clinicas de Ribeirao Preto -- Universidade de Sa Neurologia, Ribeirão Preto
Hospital Sao Paulo -- Escola Paulista de Medicina -- UNIFESP, São Paulo
Hospital das Clinicas da Fac de Medicina de Sao Paulo, São Paulo
Foothills Medical Center, Calgary
Glenrose Rehabilitation Center, Edmonton
Health Sciences Centre, St. John's
CHUM -- Hôpital Notre-Dame, Montreal
Centro Medico, Mexico City
instituto Nacional de Neurologia y Neurocirugia, Mexico City
Lead Sponsor
Bausch Health Americas, Inc.
INDUSTRY
GlaxoSmithKline
INDUSTRY